Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:1 Number:4 ISSN#:2564-2537
RCT
ACE Report #10012
Ace Report Cover Spine

Transdermal buprenorphine offers analgesia similar to oral tramadol in post-spinal fusion management


How to Cite

OrthoEvidence. Transdermal buprenorphine offers analgesia similar to oral tramadol in post-spinal fusion management. ACE Report. 2018;7(1):4. Available from: https://myorthoevidence.com/AceReport/Report/10012

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial

Eur Spine J. 2017 Nov;26(11):2961-2968

Contributing Authors: HJ Kim CK Lee JS Yeom BS Chang HS Ahn Y Nam

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

71 patients scheduled for single-level posterior lumbar interbody fusion were randomized to postoperative analgesia, beginning at 36 hours after surgery, with either transdermal buprenorphine patches or oral tramadol. Transdermal buprenorphine patch doses ranged from 5-20ug/hr and were replaced every 7 days, while oral tramadol doses ranged from 150-300mg daily. Patients were assessed for pain sco...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.